CALCICHEW 500 Milligram Tablets Chewable

Pays: Irlande

Langue: anglais

Source: HPRA (Health Products Regulatory Authority)

Ingrédients actifs:

CALCIUM CARBONATE

Disponible depuis:

Takeda UK Limited

Code ATC:

A12AA04

DCI (Dénomination commune internationale):

CALCIUM CARBONATE

Dosage:

500 Milligram

forme pharmaceutique:

Tablets Chewable

Type d'ordonnance:

Product not subject to medical prescription

Domaine thérapeutique:

Calcium

Statut de autorisation:

Transfer Pending

Date de l'autorisation:

2014-01-06

Notice patient

PATIENT INFORMATION LEAFLET
CALCICHEW*
500 MG CHEWABLE TABLETS
calcium carbonate
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Always take this medicine exactly as described in this leaflet or as
your doctor or pharmacist
have told you.
-
Keep this leaflet. You may need to read it again.
-
Ask your pharmacist if you need more information or advice.
-
You must talk to a you do not feel better or if you feel worse after
two weeks.
-
If you get any side effects talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
IN THIS LEAFLET:
1.
What Calcichew 500 mg is and what it is used for
2.
What you need to know before you take Calcichew 500 mg
3.
How to take Calcichew 500 mg
4.
Possible side-effects
5.
How to store Calcichew 500 mg
6.
Contents of the pack and other information
1.
WHAT CALCICHEW
500 MG IS AND WHAT IT IS USED FOR
Calcichew
500 mg Chewable Tablets are orange flavoured chewable tablets
containing the active
ingredient calcium. Calcium is found in the diet and is an important
substance in bone formation.
Calcichew
500 mg is used to treat and prevent calcium deficiency which may occur
if your diet or
lifestyle does not provide enough, or when body requirements are
increased. This medicine may also
be prescribed or recommended for certain bone conditions, for example
osteoporosis, or during
pregnancy. It may also be given to patients receiving kidney dialysis
to remove the phosphate from
the blood that cannot be removed by dialysis.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE CALCICHEW 500 MG
DO NOT TAKE CALCICHEW
500 MG CHEWABLE TABLETS IF YOU:

are allergic (hypersensitive) to calcium or any of the other
ingredients of this medicine (listed
in section 6)

have a condition that causes excessive amounts of calcium in your
blood or urine
(hypercalcaemia or hypercalciuria)

have kidney stones.
WARNINGS AND PRECAUTIONS
TALK TO YOUR DOCTOR OR PHARMACIST BEFORE TAKING

Résumé des caractéristiques du produit

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Calcichew 500mg Chewable Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each chewable tablet contains calcium carbonate 1250 mg equivalent to
500mg of elemental calcium.
Excipients with known effect:
Isomalt (E953) – 62 mg
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Chewable Tablet.
Round, white, uncoated and convex tablet. May have small specks.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
To correct calcium deficiency states and maintain appropriate balance
in such disorders as osteoporosis, osteomalacia,
rickets, tetany, malabsorption states and in pregnancy and lactation.
As a phosphate binding agent in the management of renal failure in
patients on renal dialysis.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
POSOLOGY
_ADULTS:_
Adjunctive therapy in osteoporosis:
2 to 3 tablets daily.
Prevention and treatment of calcium
deficiency:
2 to 3 tablets daily.
Phosphate binder:
Dose as required by the individual patient depending on serum
phosphate
level.
SPECIAL PATIENT POPULATIONS
_ELDERLY PATIENTS:_
Dosage as for adults.
_PAEDIATRIC PATIENTS:_
Prevention and treatment of calcium
deficiency:
2 to 3 tablets daily.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_2_
_/_
_0_
_5_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_2_
_1_
_8_
_7_
_7_
_3_
_4_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
Phosphate Binder:
Dose as required by the individual patient depending on serum
phosph